Trials / Conditions / Muckle-Wells Syndrome

Muckle-Wells Syndrome

8 registered clinical trials studyying Muckle-Wells Syndrome — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Circadian Rhythm Deregulation in Patients With CAPS NCT06544018	Hospices Civils de Lyon	N/A
Completed	Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Peri NCT01576367	Novartis Pharmaceuticals	Phase 3
Completed	Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Peri NCT01302860	Novartis Pharmaceuticals	Phase 3
Withdrawn	A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Dise NCT01211977	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	Phase 1 / Phase 2
Completed	Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopy NCT00991146	Novartis Pharmaceuticals	Phase 3
Completed	Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS) NCT01045772	Charite University, Berlin, Germany	Phase 2
Completed	Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial NCT00685373	Novartis	Phase 3
Completed	Efficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells Syndrome NCT00465985	Novartis	Phase 3